FDA•
Proin ER Tablets
Pegasus recalls Proin ER 145mg tablets for dogs due to failed dissolution specs.
Filters
Category
Agency
Severity
Date
Distributed in
Drugs Recalls
Back to home ←
FDA•Ascend Laboratories: Multiple Dabigatran Etexilate CapsulesAscend recalls Dabigatran Etexilate Capsules (150 mg, 75 mg) over impurity/degradation failures.
3 products
FDA•Mycophenolate Mofetil for InjectionMylan recalls Mycophenolate Mofetil for Injection 500 mg vials due to precipitate.
FDA•Glycopyrrolate Oral SolutionPrecision Dose recalls Glycopyrrolate Oral Solution over an unidentified impurity.
FDA•Cetirizine Hydrochloride Tablets 5 mgRising Pharma recalls Cetirizine HCl 5 mg tablets over Ranitidine cross-contamination.
FDA•LOWLidolog KitLidolog Kit is being recalled because the label wrap obscures the barcode, making it difficult to scan.
FDA•Trokendi XR 25mg CapsulesSupernus Pharmaceuticals is recalling Trokendi XR 25mg capsules due to failed dissolution specifications.
- FDA•Ascend Laboratories: Multiple Dabigatran Etexilate Capsules
Ascend Laboratories is recalling 110 mg and 150 mg Dabigatran etexilate capsules due to failed impurity and degradation specifications.
2 products 
FDA•Divalproex Sodium Delayed-Release TabletsBionpharma is recalling 500 mg Divalproex Sodium Delayed-Release Tablets due to the presence of foreign tablets or capsules in the bottles.
FDA•LOWFexofenadine Hydrochloride Tablets 180 mgOhm Laboratories is recalling 180 mg Fexofenadine Hydrochloride tablets due to failed impurities and degradation specifications.